Extensive Disease Small Cell Lung Cancer
5 clinical trials · Condition
◉ Watch Extensive Disease Small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| The Biomarker Exploratory Study in Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2) (NCT04818983) | Chugai Pharmaceutical | 2021-04-07 |
| Prospective Multicenter Observational Study of Atezolizumab Combination Therapy in Lung Cancer (J-TAIL-2) (NCT04501497) | Chugai Pharmaceutical | 2020-08-21 |
| Sintilimab Combined With Anlotinib as Second or Further-line Therapy for ED-SCLC (NCT04055792) | Henan Cancer Hospital | 2019-09-11 |
Track Extensive Disease Small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.